Accell Clinical Research
Private Company
Funding information not available
Overview
Accell Clinical Research is a private, European CRO with a strong operational footprint in Eastern Europe and the CIS region, offering full-service clinical trial management. It differentiates itself through deep regional expertise, a dedicated oncology subdivision (Accell Oncology), and claims superior patient enrollment rates compared to global averages in several therapeutic areas. The company targets sponsors seeking faster recruitment and cost-effective trial execution in its core geographies, operating as a revenue-generating services business.
Technology Platform
Operational network and regional expertise for clinical trial management in Eastern Europe/CIS, with a dedicated oncology subdivision (Accell Oncology) and claimed superior patient enrollment metrics.
Opportunities
Risk Factors
Competitive Landscape
Competes against large, global full-service CROs (e.g., IQVIA, PPD, ICON) and other regional CROs specializing in Eastern Europe. Differentiates through deep local expertise, a dedicated oncology team, and data claiming significantly faster patient enrollment rates in its geographic focus area.